Search

everythinglearnresearchcommunity

for

Search:↓

Early-onset hair loss in young males is linked to a higher risk of metabolic syndrome.

Metabolic Syndrome is linked to several skin conditions, and stem cell therapy might help treat them.

Women with severe types of PCOS are more likely to have metabolic syndrome, and belly fat is a key predictor of this risk.

Lower vaspin levels in the blood may indicate a better response to fertility treatment in women with PCOS.

Balding people may have higher heart disease risk.

Winter provides the best fur quality for Rex rabbits due to seasonal changes in specific signaling pathways.

Ketoconazole reduced hair growth and improved acne in women, but caused side effects needing careful monitoring.

More PDCD4 is linked to obesity, insulin problems, and cell death in ovaries for those with polycystic ovary syndrome.

Metabolic syndrome's individual issues are real and need treatment to reduce diabetes and heart disease risks.

Men with benign prostatic hyperplasia are more likely to have metabolic syndrome than those without it.

The French Endocrine Society suggests diagnosing PCOS with two of three signs, recommends lifestyle changes and clomiphene for treatment, and calls for more research on certain treatments and tests.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

People with Parkinson's disease have higher levels of cortisone in their hair, which may indicate chronic stress hormone dysfunction.

Finasteride causes harmful organ changes in female mice.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

Testosterone is linked to cardiovascular risk factors and stroke, but its exact role is unclear.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

In Japan, sex reassignment surgery for gender identity disorder faces challenges and needs better medical support and education.

Metformin and rosiglitazone improve blood vessel function in women with PCOS, with metformin also reducing insulin resistance and testosterone levels.

Women with PCOS have similar levels of certain proteins compared to women without PCOS, and these proteins don't independently cause PCOS.

Testosterone replacement therapy improves libido, mood, muscle strength, and bone density in men with Testosterone Deficiency Syndrome.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

Povidone-iodine nail solution effectively treats nail infections caused by chemotherapy.

Laser treatment is safe and can effectively treat toenail fungus, especially when combined with other treatments if no improvement is seen after about a year.

PCOS is a common hormonal disorder in women that can lead to various health issues and requires comprehensive management.

Insulin resistance contributes to hormone imbalances in many women with polycystic ovary syndrome.

Hyperandrogenism increases heart disease risk in premenopausal women, but this risk is linked to obesity in postmenopausal women.

People with androgenic alopecia (AGA) have a higher chance of getting metabolic syndrome.

Model improves accuracy in predicting hair loss effects.

Testosterone supplements can increase muscle mass and strength in older men with low levels, but long-term effects and risks need more research.